Clinical Studies Clinical Trials Cancer Research Neuroscience Neuroscience Research Epidemiology Genetic Research Vaccine Development Diabetes Research Neurological Studies Autism Studies Pharmaceutical Research Translational Research Collaborative Studies Pharmacology Virology Allergy Studies Public Health Nobel Prize Genetics Therapeutic Development Public Health Research Genetic Studies Sleep Studies Immunological Research Drug Development Vaccine Studies Epidemiological Studies Animal Studies NIH Funding Ethics in Research Immunology Animal Models Dental Research Health Studies Neurology Collaborative Research Aging Studies Study Findings Cancer Studies Neurodegenerative Diseases Innovations in Medicine Stem Cell Research Pharmaceuticals Therapeutics Cancer Treatments Funding Brain Health Cannabis Research Long-term Studies Synthetic Biology Women's Health Climate Research Cellular Reprogramming Neurology Studies Diagnostic Technology Alzheimer's Disease Study Design Case Study Nerve Injury Animal Research Psychedelics Cell Division Research Alzheimer's Disease Research Genetic Impact Radiology Studies International Collaboration Innovation Cell Biology Telemedicine Studies Breast Cancer Research Disease Mechanisms Transgender Health Biomarker Discovery Gender-Affirming Treatments Pain Studies Publications Transgender Studies Drug Safety Cardiovascular Studies Neuro-Oncology Research Output Neuroscience Studies Gene Therapy Research Cellular Stress Vaccine Innovation Peer Review Viral Mechanisms Gene Research Personalized Medicine Gerontology Cancer Treatment Innovations Viral Pathogenesis Dermatology Speech Analysis Aging Biology Hearing Restoration Acetaminophen Studies Grant Applications Health Technology
Researchers report extreme seasonal spikes of the cyanobacterial neurotoxin 2,4-DAB in dolphin brains during harmful algal blooms.